Medicine and Dentistry
Psoriasis
100%
Systemic Therapy
23%
Skin Cancer
22%
Systemic Vascular Resistance
19%
Syphilis
19%
Neck
19%
Melanoma
19%
Phototherapy
16%
Blood Flow
13%
Dermatoscopy
12%
Basal-Cell Carcinoma
11%
Arm
11%
Nail
10%
Tumor Necrosis Factor
10%
Vitiligo
9%
Alpha Adrenergic Receptor Blocking
9%
Psoralen
9%
Sun Exposure
9%
Neoplasm
9%
Calcineurin Inhibitor
9%
Metabolic Syndrome
9%
Protein P53
9%
Cryotherapy
9%
Immunosuppressive Drug
9%
Etretinate
9%
Ciclopirox
9%
Latent Syphilis
9%
Carcinoma
9%
Ultraviolet Radiation
9%
Trichophyton
9%
Natural Killer Cell
9%
Microsporum
9%
Onychomycosis
9%
Pigmented Lesion
9%
Pathogenic Fungus
9%
Rhinophyma
9%
Medical Procedures
9%
Dermatomycosis
9%
Hypertrophic Scar
9%
Polydeoxyribonucleotide
9%
Intralesional Drug Administration
9%
Skin Care
9%
B-Cell Chronic Lymphocytic Leukemia
9%
Disease Severity
9%
Immunoglobulin
9%
Vaccination Coverage
9%
Intravenous Immunoglobulin Therapy
9%
Erythema Multiforme
9%
Observational Study
9%
Oral Pathology
9%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
80%
Systemic Treatment
20%
Ciclopirox
19%
Onychomycosis
19%
Protein P53
19%
Skin Cancer
19%
Observational Study
19%
Monotherapy
12%
Placebo
12%
Disease Severity
11%
Infectious Agent
11%
Methotrexate
9%
Metabolic Syndrome X
9%
Amorolfine
9%
Tacrolimus
9%
Cohort Study
9%
Erythema Multiforme
9%
Erythroderma
9%
Sun Exposure
9%
Etretinate
9%
Psoralen
9%
Carcinoma
9%
Antiinfective Agent
9%
Ultraviolet Radiation
9%
Microflora
9%
Placebo-Controlled Study
9%
Biopolymer
9%
Non Melanoma Skin Cancer
9%
Rosacea
9%
Immunoglobulin
9%
Chronic Lymphatic Leukemia
9%
Atopic Dermatitis
9%
Immunotherapy
9%
Cell Cycle Protein
9%
Survivin
9%
Apoptosis Regulatory Protein
9%
Protein Bax
9%
Apoptosis Inhibitor
9%
Mutagenic Agent
9%
Growth Disorder
9%
Neoplasm
9%
Staphylococcus Aureus
7%
Squamous Cell Carcinoma
6%
Hesperidin
6%
Chalcone
6%
Dextran Sulfate
6%
Retinal
6%
Biological Product
6%
Ciprofloxacin
5%
Erythromycin
5%
Immunology and Microbiology
Atopic Dermatitis
39%
Blood Flow
22%
Systemic Vascular Resistance
19%
Comorbidity
17%
Common Variable Immunodeficiency
9%
Biological Product
9%
Paraffin Embedding
9%
Alpha Adrenergic Receptor Blocking
9%
Immunoreactivity
9%
Human Tissue
9%
Western Blot
9%
Microflora
9%
Tumor Necrosis Factor Alpha
9%
Adalimumab
9%
Gene Mutation
9%
Staphylococcus Aureus
7%
Laser Flowmeter
7%
Treponema pallidum
7%
Vascular Resistance
6%
Information Retrieval
6%
Microorganism
5%
